{"schema_version":"secwatch.filing_event.v1","accession":"0001628280-24-022885","form_type":"8-K","ticker":null,"cik":"0001769804","company_name":"Augmedix, Inc.","filed_at":"2024-05-13T23:59:59+00:00","discovered_at":"2026-05-14T18:03:19.985175+00:00","generated_at":"2026-06-02T02:33:45.602040+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Augmedix Q1 revenue up 40% to $13.5M; guides FY24 lower on AI purchasing slowdown","bullets":["Revenue $13.5M (+40% YoY); gross margin 47.1% (up 150 bps).","Net loss $6.5M vs $5.2M; adjusted EBITDA loss $5.1M vs $4.3M.","Dollar-based Net Revenue Retention 143% vs 136% for Health Enterprise.","CEO cites slower purchasing commitments; full-year revenue outlook lowered.","Cash $37.3M; HCA Healthcare planning expansion of Augmedix Go to more EDs."],"urls":{"canonical":"https://secwatch.observer/filing/0001628280-24-022885","json":"https://secwatch.observer/filing/0001628280-24-022885.json","markdown":"https://secwatch.observer/filing/0001628280-24-022885.md","text":"https://secwatch.observer/filing/0001628280-24-022885.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1769804/000162828024022885/0001628280-24-022885-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1769804/000162828024022885/augx-20240513.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-02T02:33:45.602040+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"11eaae11400d42bf19b89f16772f196ca551c878","claim":"Augmedix, Inc. reported first quarter ended March 31, 2024 results: revenue $13,471, net income $(6,499), EPS $(0.12).","evidence_excerpt":"healthcare systems and clinicians who are helping us optimize our suite of solutions.” 1 Three Months Ended March 31, Financial Highlights: 2024 2023 Change Revenues $13,471 $9,628 40% Gross profit $6,341 $4,386 45% Gross margin 47.1 % 45.6 % 150 bps Net loss $(6,499) $(5,239) (24)% Loss per share $(0.12) $(0.14) 14% Adjusted EBITDA (non-GAAP)","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1769804/000162828024022885/0001628280-24-022885-index.htm","confidence":0.95,"family_label":"Earnings Releases","details":[{"label":"Period","value":"first quarter ended March 31, 2024"},{"label":"Revenue","value":"$13,471"},{"label":"Net income","value":"$(6,499)"},{"label":"EPS","value":"$(0.12)"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}